Fast-Track Radiation and Chemotherapy for Esophageal Cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests a shorter course of combined radiation therapy and chemotherapy (using drugs called paclitaxel and carboplatin) to treat esophageal cancer with the goal of curing it. The faster treatment schedule may help patients finish therapy sooner while still being effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer (or cancer at the junction where the esophagus meets the stomach) that has been confirmed by biopsy
- Your cancer has not spread to distant parts of your body, confirmed by a PET/CT scan
- Your cancer is at a stage where combining radiation and chemotherapy with curative intent is appropriate
- Your blood counts, kidney function, and liver function are adequate to safely receive chemotherapy and radiation
- You have not received prior chemotherapy or radiation therapy to your chest or upper abdomen
- You do not have an esophageal stent in place, are not pregnant or breastfeeding, and have no active uncontrolled infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding medicines that block TGF-beta and PD-L1 to standard chemoradiation for esophageal squamous cell cancer that can’t be removed with surgery. It aims to improve control of the cancer where it sits, while keeping treatment safe.
This study tests a new pre-surgery treatment plan that combines chemotherapy with focused, shorter-course radiation for esophagus or stomach-where-it-meets-the-esophagus (GEJ) adenocarcinoma. The goal is to shrink the tumor before surgery and improve treatment outcomes.
This trial studies whether a combination of chemotherapy and radiation can help people with advanced esophageal cancer who cannot have curative treatment. It focuses on people who are having swallowing trouble and may be able to start treatment soon.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
This Phase 2 study tests a combination of chemotherapy (5-FU/leucovorin plus irinotecan and oxaliplatin) together with radiation for certain types of esophagus/stomach-junction cancer. It may help shrink tumors and control cancer that is locally advanced but not spread to distant organs.
This trial tests a combination of an oral chemotherapy drug (paclitaxel) and radiation therapy for people with advanced esophageal cancer that cannot be removed by surgery. It may be an option if you are 70 or older or cannot tolerate IV chemotherapy and have trouble swallowing.
Hear when a new Locally Advanced Esophageal or GE Junction Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.